CA4 and neoplasm: In HepG2 tumor‐bearing mice, CAPL/PBAE/PLGA NMs exhibit excellent tumor‐targeting capabilities and significantly enhance the inhibitory effects of PTX and CA4 on tumor growth and angiogenesis.[275]